MyAverix Finance
US · Healthcare
Lexeo Therapeutics, Inc. Common Stock (LXEO)
Biotechnology
Lexeo Therapeutics, Inc. Common Stock (LXEO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LXEO
Lexeo Therapeutics, Inc. Common Stock (LXEO) — FAQ
What is LXEO's P/E ratio?
The price-to-earnings (P/E) ratio for Lexeo Therapeutics, Inc. Common Stock (LXEO) is 18.00 (data as of 2026-03-24).
Does Lexeo Therapeutics, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Lexeo Therapeutics, Inc. Common Stock (LXEO). Check the MyAverix Finance app for the latest dividend data.
What sector is Lexeo Therapeutics, Inc. Common Stock in?
Lexeo Therapeutics, Inc. Common Stock (LXEO) is classified in the Healthcare sector (Biotechnology industry).
What exchange is LXEO listed on?
LXEO is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.